Related references
Note: Only part of the references are listed.The Ghrelin Agonist TZP-101 for Management of Postoperative Ileus After Partial Colectomy: A Randomized, Dose-Ranging, Placebo-Controlled Clinical Trial
Irinel Popescu et al.
DISEASES OF THE COLON & RECTUM (2010)
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis
N. Ejskjaer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial
Mathijs C. Bunck et al.
DIABETES CARE (2009)
Diabetes mellitus and gastric emptying: questions and issues in clinical practice
Melvin Samsom et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Diabetic Gastroparesis Diagnosis and Management
Jing Mi et al.
DRUGS (2009)
Review article: gastroparesis
A. Patrick et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Botulinum toxin a for the treatment of delayed gastric emptying
Frank K. Friedenberg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia:: a randomised, placebo-controlled, double-blind, double-crossover study
F. Strasser et al.
BRITISH JOURNAL OF CANCER (2008)
A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis
Aravind Sugumar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Are gastrointestinal symptoms related to diabetes mellitus and glycemic control?
Christian A. Koch et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
A Single-Blinded, Randomized Pilot Study Evaluating Effects of Electroacupuncture in Diabetic Patients with Symptoms Suggestive of Gastroparesis
Chung-Pang Wang et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2008)
Ghrelin agonist (TZP-101): Safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study
Kenneth C. Lasseter et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
Thomas L. Abell et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2008)
Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis
Jennifer L. Maranki et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis
J. Arts et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study
R. W. McCallum et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes
Sanjay Mehra et al.
DIABETES CARE (2007)
Diabetic gastroparesis
Michael Camilleri
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gastric electrical stimulation is safe and effective: A long-term study in patients with drug-refractory gastroparesis in three regional centers
Curuchi Anand et al.
DIGESTION (2007)
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
Catherine V. Hawkyard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients
J. Lysy et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Gastroparesis: Clinical update
Moo-In Park et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses
TJ Little et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Influence of ghrelin on interdigestive gastrointestinal motility in humans
J Tack et al.
GUT (2006)
Drug Insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide
PJ Pasricha et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study
CDR Murray et al.
GUT (2005)
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial
RJ Heine et al.
ANNALS OF INTERNAL MEDICINE (2005)
Ghrelin increases food intake in obese as well as lean subjects
MR Druce et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control
M Sogabe et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?
TF Cutts et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings
J Forster et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Review article:: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
HP Parkman et al.
GASTROENTEROLOGY (2004)
Gastroparesis following kidney/pancreas transplant
AK Cashion et al.
CLINICAL TRANSPLANTATION (2004)
Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus
A Vella et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2002)
Ghrelin enhances appetite and increases food intake in humans
AM Wren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Prevalence of gastrointestinal symptoms associated with diabetes mellitus - A population-based survey of 15000 adults
P Bytzer et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial
NJ Talley et al.
GUT (2001)
Predictors of delayed gastric emptying in diabetes
KL Jones et al.
DIABETES CARE (2001)
Ghrelin strongly stimulates growth hormone (GH) release in humans
K Takaya et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial
NJ Talley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Ghrelin-induced growth hormone secretion in humans
R Peino et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans
Y Date et al.
ENDOCRINOLOGY (2000)
Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy
CC Watkins et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
